Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2025	Dec. 31, 2024
Investments:
Fixed maturities available-for-sale, at fair value (amortized cost: $237.1 million and $208.3 million, respectively)	$ 237.3	$ 205.7
Short-term investments, at fair value (amortized cost: $167.8 million and $167.6 million, respectively)	167.8	167.6
Total investments	405.1	373.3
Cash and cash equivalents	198.9	197.6
Restricted cash	26.9	35.2
Accounts receivable, net of allowance of $0.2 million and $0.6 million, respectively	227.1	167.0
Reinsurance recoverable on paid and unpaid losses and LAE	302.6	285.3
Prepaid reinsurance premiums	296.4	274.2
Ceding commissions receivable	107.7	79.5
Capitalized internal use software	47.2	48.1
Intangible assets	14.3	17.0
Assets held for sale	4.7	0.0
Other assets	75.3	66.2
Total assets	1,706.2	1,543.4
Liabilities:
Loss and loss adjustment expense reserve	389.0	350.0
Unearned premiums	506.2	457.9
Reinsurance premiums payable	302.9	248.6
Provision for commission	38.4	34.3
Surplus note	47.9	0.0
Liabilities held for sale	10.5	0.0
Accrued expenses and other liabilities	77.2	87.4
Total liabilities	1,372.1	1,178.2
Commitments and contingencies (Note 13)
Stockholders’ equity:
Common stock, $0.0001 par value per share; 80,000,000 shares authorized as of June 30, 2025 and December 31, 2024; 25,543,053 and 24,866,803 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively	0.0	0.0
Additional paid-in capital	1,653.7	1,639.7
Accumulated other comprehensive income (loss)	0.1	(2.7)
Accumulated deficit	(1,321.3)	(1,274.9)
Total Hippo stockholders’ equity	332.5	362.1
Noncontrolling interest	1.6	3.1
Total stockholders’ equity	334.1	365.2
Total liabilities and stockholders’ equity	$ 1,706.2	$ 1,543.4
Common stock, shares outstanding (in shares)	25,543,053	24,866,803
Common stock, shares issued (in shares)	25,543,053	24,866,803